Tuberculosis Clinical Trial
Official title:
Effect of Continuous Positive Airway Pressure on Fluid Absorption Among Patients With Pleural Effusion Due to Tuberculosis
Tuberculosis (TB) remains as an important public health problem worldwide. Pleural
tuberculosis is the most prevalent form of extrapulmonary presentation in immunocompetent
patients.
The volume of effusion in the pleural space of patients with pleural TB may cause
complications like restrictive ventilator lung functional disturb and/or pleural thickening.
The respiratory physiotherapy can be adjuvant on treatment of pleural effusion tuberculosis
throughout of various treatment technique.
The Continuous positive airway pressure (CPAP) is utilized in various pathologic, this
improves lung mechanics by recruiting atelectatic alveoli, improving pulmonary compliance,
and reducing the work of breathing.
The aim of this study is to determine the effect of CPAP on fluid absorption among patients
with pleural effusion due tuberculosis.
This randomized and controlled trial compared the reduction of the pleural effusion volume
of the group of patients using the anti-TB standard regimen to that using the anti-TB
standard regimen AND adjuvant treatment of physical therapy during four weeks.
- Control group: The patients received rifampicin, isoniazid and pyrazinamide
daily(anti-TB standard regimen)
- Interventional group: The patients received anti-tb standard regime and Continuous
Positive Airway Pressure (CPAP) 3 times a week for 30 minutes with positive expiratory
end pressure of 10 cmH2O.
Evaluation of the pleural effusion size: a helicoidal thoracic computed tomography (CT) was
carried out in all patients enrolled. The valuation was conducted by two radiologists
blinded for the treatment used, specifically trained for the purpose of the study.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05738681 -
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT05526885 -
Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa
|
N/A | |
Completed |
NCT04369326 -
Community Initiated Preventive Therapy for TB
|
N/A | |
Recruiting |
NCT04568967 -
TB-CAPT EXULTANT - HIV
|
N/A | |
Completed |
NCT02337270 -
Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol
|
Phase 1 | |
Not yet recruiting |
NCT06253715 -
Shortened Regimen for Drug-susceptible TB in Children
|
Phase 3 | |
Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
Withdrawn |
NCT03639038 -
Tuberculosis Diagnosis by Flow Cytometry
|
||
Completed |
NCT03199313 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
|
Phase 1 | |
Recruiting |
NCT04975178 -
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
|
Phase 3 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03973970 -
Assessing the Ability of the T-SPOT®.TB Test (IQ)
|
||
Recruiting |
NCT04230395 -
Alcohol Reduction Among People With TB and HIV in India
|
N/A | |
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Active, not recruiting |
NCT02906007 -
Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05917210 -
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
|
N/A | |
Not yet recruiting |
NCT05845112 -
Start Taking Action For TB Diagnosis
|
||
Not yet recruiting |
NCT06017843 -
Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
|
N/A | |
Active, not recruiting |
NCT02715271 -
Study of TB Lesions Obtained in Therapeutical Surgery
|
||
Completed |
NCT02781909 -
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis
|
Phase 2 |